abYsis: Integrated Antibody Sequence and Structure-Management, Analysis, and Prediction

Area of Science:

• * Immunology and Bioinformatics
• * Computational Biology and Drug Discovery

Background:

• * Antibody research requires integrated sequence and structure data analysis.
• * Existing tools lack comprehensive features for antibody engineering and drug development.

Purpose of the Study:

• * To introduce abYsis, a web-based system for antibody sequence and structure data analysis.
• * To provide researchers with tools for enhanced antibody engineering and drug development.

Main Methods:

• * Integrated database of antibody sequence and structure data.
• * Web-based interface for data interrogation using text, sequence, and 3D structural queries.
• * Automatic sequence numbering (e.g., Kabat, Chothia) and annotation (e.g., CDRs, PTMs).
• * Residue frequency tables for analyzing unusual residues and mutation acceptability.

Main Results:

• * abYsis offers comprehensive analysis of antibody sequence and structure data.
• * Automatic numbering and annotation streamline the analysis of antibody features.
• * Residue frequency tables facilitate the identification of acceptable mutations and inter-species comparisons.

Conclusions:

• * abYsis is a valuable tool for antibody engineering, particularly for drug development.
• * The system aids researchers in making informed decisions regarding antibody design and optimization.
• * abYsis enhances the efficiency and accuracy of antibody research through integrated data and analysis tools.